Tolerance to early human milk feeding is not compromised by indomethacin in preterm infants with persistent ductus

M Bellander1, D Ley, S Polberger

  • 1Department of Paediatrics, University Hospital, Lund, Sweden.

Insights

Early human milk feeding is safe for preterm infants with persistent ductus arteriosus (PDA) treated with indomethacin. This feeding strategy shows good tolerance and comparable outcomes to controls, supporting its use in neonatal care.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Perinatology

Background:

  • Early human milk feeding is crucial for preterm infant gut and brain development.
  • Persistent ductus arteriosus (PDA) and its treatment with indomethacin can potentially affect enteral feeding tolerance.
  • Current practice often continues enteral milk feedings in preterm infants with PDA receiving indomethacin.

Purpose of the Study:

  • To evaluate the safety and tolerance of early enteral feeding with human milk in preterm infants treated with indomethacin for PDA.
  • To compare feeding outcomes and complications between preterm infants with PDA receiving indomethacin and matched controls.

Main Methods:

  • Retrospective study of 64 preterm infants (<29 wk gestational age).
  • 32 infants received indomethacin for symptomatic PDA (case group) and 32 were matched controls.
  • Comparison of gestational age, body weight, respiratory morbidity, feeding initiation, volumes, gastric residuals, and necrotizing enterocolitis rates.

Main Results:

  • No significant differences in the initiation of human milk feeding between case and control infants (median 4.0h vs 5.3h).
  • Similar feeding volumes and gastric residuals were observed in both groups during the first 7 days of life.
  • The incidence of necrotizing enterocolitis was comparable, with two cases in each group.

Conclusions:

  • Early enteral feeding with human milk, initiated within hours of birth, is well-tolerated in preterm infants undergoing indomethacin treatment for PDA.
  • This feeding strategy appears as safe and effective as in preterm infants without PDA requiring indomethacin.
  • Findings support the continuation of early human milk feeding in this vulnerable population.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...